The library subject alerts have been retired in favour of a more tailored alert service.
If you would like to receive an alert targeted to your interests, please submit a Subject alert request.
Chaperones in urology clinic: an updated survey of patient perspectives and preferences in the outpatient setting in the United Kingdom Postgraduate Medical Journal. 2025;101(1202):1273–1279
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40450578
Coexistence of IgG4-Related Disease and Renal Anastomosing Hemangioma: A Rare Diagnostic Challenge Internal Medicine. 2025;64(23):3447–3452
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40399091
Comparative efficacy and safety of febuxostat and allopurinol in chronic kidney disease stage 3-5 patients with asymptomatic hyperuricemia: a network meta-analysis Renal Failure. 2025;47(1):2470478
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40012480
A Diagnostic Blind Spot in Pseudo-Bartter Syndrome: Aberrant Renin-angiotensin-aldosterone System Activation from Focal Renal Scarring Internal Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41224275
Discordance in Creatinine- and Cystatin C-Based eGFR and Clinical Outcomes: A Meta-Analysis JAMA. 2025;334(21):1915–1926
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41202182
Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial Lancet. 2025;406(10516):2221–2234
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41115436
Effect of roxadustat on lowering blood lipids in peritoneal dialysis patients with anemia Renal Failure. 2025;47(1):2460726
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40000368
Front-line durvalumab and BCG in the treatment of non-muscle-invasive bladder cancer Lancet. 2025;406(10516):2192–2194
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41115438
Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023 Lancet. 2025;406(10518):2461–2482
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41213283
Impact of Atherosclerotic Conditions and Cardiovascular Medications on Abdominal Aortic Aneurysm Growth American Journal of Medicine. 2025;138(12):1689–1696.e3
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40578465
Individualized Perioperative Blood Pressure Management in Patients Undergoing Major Abdominal Surgery: The IMPROVE-multi Randomized Clinical Trial JAMA. 2025;334(21):1893–1904
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41076588
Kidney function and cognitive impairment: a systematic review and meta-analysis Renal Failure. 2025;47(1):2463565
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40037396
Latent Tubulointerstitial Nephritis with IgM-positive Plasma Cells Uncovered in a Case of IgA Nephropathy and Primary Biliary Cholangitis: Clinical and Histological Insights Internal Medicine. 2025;64(22):3266–3271
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40368788
Lower Urinary Tract Symptoms in Males JAMA. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41222924
Malignancy-associated Multicentric Reticulohistocytosis Mimicking Dermatomyositis-like Features, with a Significant Ultrasound Finding Internal Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41192909
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy New England Journal of Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41196369
A preventive care strategy to reduce moderate or severe acute kidney injury after major surgery (BigpAK-2); a multinational, randomised clinical trial Lancet. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41242333
Proteinuria or Albuminuria as Markers of Kidney and Cardiovascular Disease Risk : An Individual Patient-Level Meta-analysis Annals of Internal Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41183334
SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis JAMA. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41203232
Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial New England Journal of Medicine. 2025
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41211929
Significance of Serum Cholinesterase as a Prognostic Marker in Patients with Non-dialysis-dependent Chronic Kidney Disease Internal Medicine. 2025;64(22):3188–3196
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40436752
Suicide risk in patients undergoing hemodialysis: a systematic review and meta-analysis of prevalence Renal Failure. 2025;47(1):2521453
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=40571671
Supporting Shared Decision-Making in Life-Altering Kidney Therapy Decisions for Older Adults: A Review JAMA Intern Med. 2025;185(12):1479–1488
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41143833
Survival Benefits of Deceased Donor Kidney Transplant vs Waitlisting JAMA Intern Med. 2025;185(12):1471–1478
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41143824
Urodynamic testing in refractory overactive bladder symptoms: the FUTURE study Lancet. 2025;406(10517):2322
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=41241511